Antidepressant activity of Channa striatus Bloch extracts in rodents and their possible mechanism
Depression is a major mood disorder. Despite the availability of effective pharmacotherapy, around 30% of patients do not respond to current treatments. Several natural products exhibited antidepressant activity in previous studies. Channa striatus (Malay: Haruan) exhibited antinociceptive effect...
Saved in:
Main Author: | |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2016
|
Online Access: | http://psasir.upm.edu.my/id/eprint/66948/1/FPSK%28p%29%202016%2032%20IR.pdf http://psasir.upm.edu.my/id/eprint/66948/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Putra Malaysia |
Language: | English |
Summary: | Depression is a major mood disorder. Despite the availability of effective
pharmacotherapy, around 30% of patients do not respond to current treatments. Several
natural products exhibited antidepressant activity in previous studies. Channa striatus
(Malay: Haruan) exhibited antinociceptive effect in mice through serotonergic system.
Dysfunction of serotonergic system has been associated with depression and many
antidepressant drugs act through it. Hence, this study evaluated the antidepressant
activity of extracts of C. striatus in rodents and their mechanism of action. Aqueous and
lipid extracts were prepared from the fillet of C. striatus and their individual components
were quantified. Both extracts were tested in forced swimming test (FST), tail suspension
test (TST) and open field test (OFT) in male ICR mice. The mechanism of action was
evaluated by pretreatment with selected monoamine antagonists. The lipid extract was
tested in postpartum depression (PPD) model in female Sprague-Dawley rats and chronic
unpredictable mild stress model (CUMS) in male Sprague-Dawley rats through FST and
OFT. The plasma levels of corticosterone, oxytocin, brain prefrontal cortex and
hippocampal levels of monoamines, brain-derived neurotrophic factor (BDNF),
interleukin-6 (IL-6) and nuclear factor-kappa B (NF-κB) were determined by ELISA in
PPD and CUMS experiments. Additionally, body weight and sucrose preference were
measured at every week during CUMS study. Analysis of variance followed by
appropriate post hoc test was used as the statistical test with significance considered at p
< 0.05. The aqueous extract produced significant (p < 0.001) antidepressant activity in
FST and TST and its mechanism was found to be acting through the serotonergic system
and noradrenergic system. In another experiment, aqueous and lipid extracts, prepared
by a different method, produced significant (p < 0.05) antidepressant activity in FST and
TST through serotonergic and noradrenergic systems. The lipid extract was found to
contain oleic acid, palmitic acid as major fatty acids along with docosahexaenoic acid.
The aqueous extract was found to contain aspartic acid and glutamic acid as major amino
acids. The lipid extract produced significant (p < 0.001) antidepressant effect in PPD
model, with the mechanism mediated through the decrease in corticosterone, increase in oxytocin and decrease in NF-κB in prefrontal cortex. The lipid extract produced
significant (p < 0.001) antidepressant effect in FST in CUMS model, with the mechanism
mediated through the decrease in corticosterone, increase in serotonin level in prefrontal
cortex, increase in dopamine and noradrenaline levels in hippocampus and prefrontal
cortex, increase in BDNF level in hippocampus and prefrontal cortex, and decrease in
IL-6 and NF-κB levels in prefrontal cortex. The lipid extract also significantly (p < 0.05)
reversed the effects of stress on body weight of animals and sucrose preference in CUMS
model. In conclusion, the aqueous and lipid extracts of C. striatus produced significant
antidepressant effect in animal models of depression with the common mechanism of
action through monoaminergic systems. These findings may be useful to explore further
the clinical utility and molecular mechanism of action of these extracts. |
---|